Tinnitus (ringing in the ears) Board decisions

The Board granted service connection for tinnitus, finding that new and relevant evidence was submitted and the Veteran's tinnitus is related to his noise exposure during service.

The Board denied service connection for bilateral hearing loss and remanded the claims for tinnitus and squamous cell carcinoma due to a need for further development.

The Board denied service connection for left ankle and mental health disabilities, but granted service connection for eye condition (vision) and tinnitus for purposes of health care benefits under Chapter 17, Title U.S.C.

The Board denied service connection for erectile dysfunction, tinnitus, and GERD due to the lack of a current diagnosis. The Veteran's other specified traumatic and stressor related disorder was rated at 70%, hypertension and other headaches were not rated compensably, and effective dates prior to March 11, 2020, and November 12, 2021, for service connection were denied.

The Board remands the claims for service connection for bilateral hearing loss and tinnitus for additional development, including obtaining a new medical opinion to address in-service noise exposure and delayed onset hearing loss.

The Board remands the claims for service connection for bilateral hearing loss and tinnitus due to a pre-decisional duty to assist error.

The Board dismissed the claim for service connection for an acquired psychiatric disability, claimed as depression and denied claims for service connection for tinnitus, sleep apnea, carpal tunnel syndrome of both upper extremities, right foot, left foot, and various other musculoskeletal conditions.

The Board denied service connection for bilateral hearing loss disability and tinnitus, finding no evidence of a current disability or nexus to in-service noise exposure.

The Board denied the veteran's claims for increased ratings and remanded several issues, including service connection for hypertension.

The Board remands the claims for service connection for bilateral hearing loss, tinnitus, headaches, and an acquired psychiatric disorder due to insufficient evidence regarding their etiology.

The Board granted a 30 percent rating for tinnitus with insomnia, finding the symptoms to be consistent with occupational and social impairment due to mild or transient symptoms which decrease work efficiency and ability to perform occupational tasks only during periods of significant stress.

The Board granted service connection for tinnitus, finding that the Veteran's noise exposure during her active service in Afghanistan supports this claim.

The Board denied the Veteran's claim for service connection for tinnitus, finding that there was no current diagnosis of tinnitus and that the evidence did not support a link between the claimed condition and military service.

The Board granted an effective date of September 1, 2021, for service connection for the Veteran's thoracic spine, cervical spine, right foot, painful scar, status-post varicocele surgery, left lower abdomen, right knee, bilateral tinnitus, and right lower extremity neuropathy disabilities.

The Board denied the veteran's claims for increased ratings for eczema, migraine headaches, irritable bowel syndrome (IBS), and tinnitus.

The Board granted service connection for tinnitus, finding an approximate balance of evidence that the condition is related to in-service noise exposure.

The Board granted service connection for tinnitus, finding that the Veteran's tinnitus was incurred in service and continued. The other claims were remanded for further development.

The Board denied service connection for tinnitus and denied earlier effective dates for increased ratings and special monthly compensation claims.

The appeal for an effective date prior to August 10, 2021, for the award of service connection for tinnitus is dismissed. The claims for service connection for jungle rot disability and bilateral ankle disabilities are denied.

The Veteran has withdrawn the appeal for service connection for bilateral hearing loss, tinnitus, and diabetes mellitus type 2.